Sorry to be the one to tell you this, but your brain has been running on a schedule designed by someone who thinks six weeks is a reasonable amount of time to wait for relief. In psychiatry, that is often the deal: one treatment session per day, over and over, while your neurons hold a staff meeting and maybe, eventually, change their minds. A new systematic review and meta-analysis asks a smarter question: what if we stop stretching the timeline and just give the brain more stimulation per day?

That is the basic idea behind accelerated repetitive transcranial magnetic stimulation, or arTMS. Instead of one daily session, patients get at least two. Same noninvasive brain stimulation, much more compressed schedule. Think of it as batch processing for neural circuits, except the circuits are mood, memory, and compulsive loops instead of your inbox.

The Brain's Overbooked Air Traffic Controller

The new paper, published online December 1, 2025, pooled 44 randomized controlled trials with 1,671 participants across 20 symptom domains [1]. That matters because most TMS conversations still orbit diagnosis labels like depression or OCD. Useful labels, sure, but brains do not read the DSM before malfunctioning.

The usual TMS target is the dorsolateral prefrontal cortex, which is a spectacularly unsexy name for a region that helps with working memory, planning, inhibition, and generally keeping your mental traffic from turning into a seven-car pileup. When this circuitry goes off-script, you can get depression, anxiety, compulsive loops, or cognitive fog. arTMS tries to nudge those networks into a better pattern through repeated magnetic pulses. Neuroplasticity, basically.

So, Did The Speedrun Work?

Mostly, yes - and not in a tiny, statistical-ghost kind of way.

Compared with sham stimulation, the meta-analysis found a moderate effect for depression, plus significant improvements in anxiety, obsessive-compulsive symptoms, working memory, and declarative memory [1]. This was not just "people felt a bit less depressed." Some domains moved more than others, which suggests arTMS may be hitting specific circuits rather than spraying hope at the skull and seeing what sticks.

That fits with where the field has been heading. A 2023 cross-diagnostic meta-analysis in The Lancet Psychiatry found that left dorsolateral prefrontal rTMS has effects that look more symptom-specific than diagnosis-specific [2]. A 2024 dose-response meta-analysis in JAMA Network Open argued that stimulation parameters matter, sometimes a lot [3]. TMS is starting to look less like "zap here for sadness" and more like network engineering with increasingly fussy settings.

The new review adds an important wrinkle: treatment response shifted with session frequency, gaps between sessions, total pulse dose, age, and sex [1]. If that holds up, future trials can stop treating every patient like the same badly photocopied template and start tuning protocols to the person in the chair.

Why Anyone Outside A Psychiatry Conference Should Care

Standard TMS can work, but it asks a lot from patients. Repeated clinic visits over four to six weeks are a logistical mess, especially for people who are depressed, working, caregiving, or all three. Accelerated protocols promise the same basic idea on a shorter clock. That is not just convenience. That is access.

This matters even more because recent high-impact studies suggest the shorter timetable is not a gimmick. A 2024 review in Molecular Psychiatry found theta-burst stimulation, a faster cousin in the TMS family, effective for depression overall [4]. Then a 2025 randomized clinical trial in JAMA Psychiatry reported that a pragmatic accelerated theta-burst protocol was safe and effective for treatment-resistant depression [5]. The field still needs better answers on durability, targeting, and who benefits most. But it is well past the stage of "cute idea, probably nonsense."

There is also a deeper shift here. Psychiatry has spent decades sorting people into boxes. arTMS research is nudging the field toward circuits and symptoms instead. If anxiety improves in one disorder and working memory improves in another, maybe those are not side quests. Maybe they are the real geometry of the problem.

The Fine Print That Actually Matters

No, this does not mean magnets are about to replace therapy, medication, sleep, sunlight, or the rest of the annoying list of things your brain keeps demanding. It does mean noninvasive neuromodulation is becoming more precise, faster, and more realistic for real patients. The review also found adverse events were generally mild and transient [1], which is exactly what you want from a treatment that sounds like a rejected sci-fi prop.

The honest takeaway is less "miracle cure" and more "the field may finally be learning the brain's timing." Give the right circuits the right dose, at the right spacing, and some stubborn symptoms start to budge. Not all. Not for everyone. But enough to make this worth watching closely.

References

1. Zhang H, Green J, Dwivedi S, Chou YH. Domain-Specific Efficacy of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropsychiatric Disorders: A Systematic Review and Meta-Analysis. Biological Psychiatry. Published online December 1, 2025. DOI: https://doi.org/10.1016/j.biopsych.2025.11.019
2. Kan RLD, Padberg F, Giron CG, et al. Effects of repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex on symptom domains in neuropsychiatric disorders: a systematic review and cross-diagnostic meta-analysis. The Lancet Psychiatry. 2023;10(4):252-259. DOI: https://doi.org/10.1016/S2215-0366(23)00026-3
3. Sabé M, Hyde J, Cramer C, et al. Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation Across Mental Disorders: A Systematic Review and Dose-Response Meta-Analysis. JAMA Network Open. 2024;7(5):e2412616. DOI: https://doi.org/10.1001/jamanetworkopen.2024.12616
4. Kishi T, Ikuta T, Sakuma K, et al. Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis. Molecular Psychiatry. 2024;29(12):3893-3899. DOI: https://doi.org/10.1038/s41380-024-02630-5
5. Ramos MRF, Goerigk S, da Silva VA, et al. Accelerated Theta-Burst Stimulation for Treatment-Resistant Depression: A Randomized Clinical Trial. JAMA Psychiatry. 2025;82(5):442-450. DOI: https://doi.org/10.1001/jamapsychiatry.2025.0013

Disclaimer: The image accompanying this article is for illustrative purposes only and does not depict actual experimental results, data, or biological mechanisms.